Open original FDA record ↗Recall record
- FDA identifier
- Z-1565-2016
- Company in FDA record
- Baxter Healthcare Corp.
- FDA record creation date
- Apr 25, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Baxter Healthcare Corporation is sending this communication to inform you of incomplete instructions in the AMIA Automated Peritoneal Dialysis (PO) System Clinician Guide for calculating the total recommended solution therapy volume. Specifically, the instructions do not specify the need for an extra 200 mL of PD solution in order to prime the patient line and for air purge operations. The tot
Source facts
- Action
- An Urgent Device Correction communication was sent to the one affected customer via U.S.P.S., first class mail on 02/11/2016. A Clinician Guide Addendum was created to instruct clinicians of the extra 200 mL of PD solution required to prime the patient line and for air purge operations. This Addendum was provided as an attachment to the Urgent Device Correction communication letter.
- Initiated
- 2016-02-16
- Root cause
- Under Investigation by firm
- Terminated
- 2016-12-23
- Distribution
- US Consignee: NY ***Foreign Consignee: Ecuador
- Recall number
- Z-1565-2016
- Recall status
- Terminated
- CDRH record ID
- 144203
- FDA record created
- 2016-04-25
- Recall event number
- 73435